Tanabes - healthylife7.com

Browsing: Tanabes

LEO Pharma buys Tanabe’s rare disease drug dersimelagon for $435 M

By healthylife7August 18, 20260

LEO Pharma, a global leader in medical dermatology delivering innovative solutions for skin disease, has entered into an agreement to acquire worldwide rights to dersimelagon from Japan-based Tanabe Pharma. Dersimelagon is an oral, once-daily small MC1R agonist being developed for erythropoietic protoporphyria (EPP) and X-linked proto-porphyria (XLP)

What's Hot

MESO Completes Patient Treatment in Chronic Back Pain Study, Stock Up

Low-fat vegan diet may help people lose weight without eating less, say researchers

Browsing: Tanabes

LEO Pharma buys Tanabe’s rare disease drug dersimelagon for $435 M

MESO Completes Patient Treatment in Chronic Back Pain Study, Stock Up

Low-fat vegan diet may help people lose weight without eating less, say researchers

Acadiana’s social scene growing beyond bars, restaurants

Opinion: The FDA must put biotech at its center or continue to cede early research to China

Inside Elevance’s digital chronic disease management strategy

Best, Worst States For Well

What do the Middle Ages tell us about mental health then and now? VCU historian Leigh Ann Craig has answers

Fitness

MESO Completes Patient Treatment in Chronic Back Pain Study, Stock Up

Low-fat vegan diet may help people lose weight without eating less, say researchers

Health

Opinion: The FDA must put biotech at its center or continue to cede early research to China

Inside Elevance’s digital chronic disease management strategy

Best, Worst States For Well

Subscribe to Updates

What's Hot

Browsing: Tanabes